Application 219531

Type
NDA
Sponsor
BRILLIAN PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SDAMLOAMLODIPINE BESYLATEFOR SOLUTION;ORALEQ 2.5MG BASE/BOTYesYes
002SDAMLOAMLODIPINE BESYLATEFOR SOLUTION;ORALEQ 5MG BASE/BOTYesYes
003SDAMLOAMLODIPINE BESYLATEFOR SOLUTION;ORALEQ 10MG BASE/BOTYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85871SUPPL 2026-05-11
83798ORIG 2025-10-17
82960ORIG 2025-07-28
82942ORIG 2025-07-25